Update on 21st Century Cures Act Implementation
January 1, 2019
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The hearing tracks the implementation of a major federal law that dictates how the FDA and NIH allocate resources and regulate medical innovation, directly impacting the speed and safety of new drug and treatment approvals.
Potentially affected actors named in the source documents. Mention is not a position.
FDA
The agency is responsible for implementing regulatory changes mandated by the 21st Century Cures Act.
NIH
The agency is responsible for executing research initiatives funded or authorized by the 21st Century Cures Act.
Last recorded activity January 1, 2019.
Next step not available in the current record.
Summary
Key Facts
- The hearing was held on July 25, 2018, to review the implementation of the 21st Century Cures Act.
- The Subcommittee on Health of the Committee on Energy and Commerce presided over the hearing.
- Witnesses included the Director of the NIH and the Commissioner of the FDA.
- The hearing included testimony from the Deputy Director of the 'All of Us' Research Program and the Director of the National Cancer Institute.
Frequently Asked Questions
What is the purpose of this hearing?
Who testified at this hearing?
Why It Matters
The hearing tracks the implementation of a major federal law that dictates how the FDA and NIH allocate resources and regulate medical innovation, directly impacting the speed and safety of new drug and treatment approvals.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance60How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools